The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III study to evaluate the efficacy and safety of GLSI-100 (GP2 + GM-CSF) in breast cancer patients with residual disease or high-risk PCR after both neoadjuvant and postoperative adjuvant anti-HER2 therapy: Flamingo-01.
 
Snehal Patel
Employment - Greenwich LifeSciences
Leadership - Greenwich LifeSciences
Stock and Other Ownership Interests - Greenwich LifeSciences
 
Jaye Thompson
Employment - Greenwich LifeSciences
Leadership - Greenwich LifeSciences
Stock and Other Ownership Interests - Greenwich LifeSciences
 
Mira Patel
Employment - Greenwich LifeSciences
Stock and Other Ownership Interests - Greenwich LifeSciences
 
F. Joseph Daugherty
Employment - Greenwich LifeSciences
Leadership - Greenwich LifeSciences
Stock and Other Ownership Interests - Greenwich LifeSciences
 
Mothaffar F. Rimawi
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genentech; Macrogenics; Novartis; Seagen
Research Funding - Genentech (Inst); Pfizer (Inst)